Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
Holding CRSP?
Track your performance easily

Crispr Therapeutics AG (CRSP) Cash flow

8,471 Followers

Crispr Therapeutics AG Cash Flow

CRSP's free cash flow for Q3 2024 was $-107.13M. For the 2024 fiscal year, CRSP's free cash flow was decreased by $263.08M and operating cash flow was $-106.91M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -188.82M$ -260.38M$ -495.74M$ 538.97M$ -238.37M$ 56.68M
Investing Cash Flow
$ -467.76M$ 374.65M$ -258.65M$ -1.04B$ -541.17M$ 1.32M
Financing Cash Flow
$ 354.05M$ 62.66M$ 38.59M$ 250.94M$ 1.02B$ 430.98M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.85B$ 401.07M$ 224.06M$ 939.94M$ 1.19B$ 948.81M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 318.46M$ 32.72M$ 970.00K$ 213.27M$ 982.29M$ 415.02M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -191.20M$ -269.85M$ -532.93M$ 457.27M$ -256.72M$ 49.99M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Crispr Therapeutics AG Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis